Clinical Trials Browser

Phase 3 × Myasthenia Gravis × Rituximab × Clear all

NCT02950155 2024-10-26

Rinomax

Phase 3 Completed

47 enrolled 24 charts

Myasthenia Gravis

NCT05332587 2022-05-02

Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis

Phase 3 Unknown

Myasthenia Gravis